Pearl River Capital, LLC Fibrogen Inc Transaction History

Pearl River Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$18.57 - $35.68 $256,024 - $491,920	-13,787 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$31.0 - $55.72 $427,397 - $768,211	13,787 New	13,787 $479,000
Q2 2019 Aug 12, 2019	SELL	$35.13 - $55.53 $1,475 - $2,332	-42 Closed	0 $0
Q1 2019 May 02, 2019	SELL	$42.83 - $59.91 $7,195 - $10,064	-168 Reduced 80.0%	42 $2,000
Q4 2018 Feb 08, 2019	BUY	$37.97 - $60.16 $7,973 - $12,633	210 New	210 $10,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.